{"disease":{"id":"mild-dementia-due-to-alzheimer-s-disease","name":"mild dementia due to alzheimer s disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03462121","title":"A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":83,"lead_sponsor_name":"Regenera Pharma Ltd","has_results":false},{"nct_id":"NCT05582941","title":"Biomarkers of Cognitive Impairment in Blood Cells","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"University of the Balearic Islands","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}